Chief Operating Officer and Chief Financial Officer-Roberto E. Cuca Senior Vice President of Strategic Operations and Marketing-Jim Hagen Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Second Quarter 26 Earnings Conference Call. At this time, all participants are in listen-only mode.
Following the prepared remarks, there will be a question-and-answer session. Please be advised that today's conference is being recorded. I would now like to turn the conference over to Louisa Smith.
Louisa Smith: Thank you, Lisa, and good afternoon, everyone. Earlier today, TELA Bio released financial results for the second quarter ended 06/30/2026. Copy of the press release is available on the company's website.
Joining me on today's call are Heather, Chief Executive Officer Jeffrey Blizard, president Roberto E. Cuca, chief operating officer and chief financial officer and Jim Hagen. Senior vice president of strategic operations and marketing.
Before we begin, I would like to remind you that during the conference call, the company may make projections and forward looking statements regarding future events. We encourage you to review the company's past and future filings with the SEC, including, without limitation, the company's quarterly reports on Forms 10-Q, Which identify the specific risk factors that may cause actual results or events to differ materially from those described in these forward looking statements. These factors may include, without limitation, statements regarding product development, pipeline opportunities, sales and marketing strategies, and the impact of various additional risk factors as identified in our regulatory filings.
With that, I will now turn the call over to Joe Capper. Antony Koblish: Thank you, Louisa. Good afternoon, and thank you for joining TELA Bio's second quarter 26 earnings call.
Extract — continue reading at the source.
